| Identification of antigens presented by MHC for vaccines against tuberculosis P Bettencourt, J Müller, A Nicastri, D Cantillon, M Madhavan, PD Charles, ... npj Vaccines 5 (1), 2, 2020 | 84 | 2020 |
| Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells NC Bull, E Stylianou, DA Kaveh, N Pinpathomrat, J Pasricha, ... Mucosal immunology 12 (2), 555-564, 2019 | 80 | 2019 |
| Identification and evaluation of novel protective antigens for the development of a candidate tuberculosis subunit vaccine E Stylianou, R Harrington-Kandt, J Beglov, N Bull, N Pinpathomrat, ... Infection and immunity 86 (7), 10.1128/iai. 00014-18, 2018 | 72 | 2018 |
| Immunogenicity and safety of an intradermal BNT162b2 mRNA vaccine booster after two doses of inactivated SARS-CoV-2 vaccine in healthy population P Intapiboon, P Seepathomnarong, J Ongarj, S Surasombatpattana, ... Vaccines 9 (12), 1375, 2021 | 43 | 2021 |
| Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model R Harrington-Kandt, E Stylianou, LA Eddowes, PJ Lim, L Stockdale, ... PLoS One 13 (1), e0191038, 2018 | 24 | 2018 |
| Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model N Pinpathomrat, N Bull, J Pasricha, R Harrington-Kandt, H McShane, ... Vaccine 39 (9), 1452-1462, 2021 | 13 | 2021 |
| Regulatory T cells decreased during recovery from mild covid-19 P Seepathomnarong, J Ongarj, R Sophonmanee, B Seeyankem, S Chusri, ... Viruses 14 (8), 1688, 2022 | 11 | 2022 |
| Coronavirus disease 2019 vaccinations in patients with chronic liver disease and liver transplant recipients: An update P Sripongpun, N Pinpathomrat, J Bruminhent, A Kaewdech Frontiers in Medicine 9, 924454, 2022 | 11 | 2022 |
| Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants S Niyomnaitham, A Jongkaewwattana, A Meesing, N Pinpathomrat, ... International Journal of Infectious Diseases 129, 19-31, 2023 | 10 | 2023 |
| T-Cell responses Induced by an intradermal BNT162b2 mRNA vaccine Booster following primary vaccination with inactivated SARS-CoV-2 vaccine R Sophonmanee, J Ongarj, B Seeyankem, P Seepathomnarong, ... Vaccines 10 (9), 1494, 2022 | 9 | 2022 |
| Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population N Pinpathomrat, P Intapiboon, P Seepathomnarong, J Ongarj, ... NPJ vaccines 7 (1), 52, 2022 | 9 | 2022 |
| MAVS deficiency is associated with a reduced t cell response upon secondary RSV infection in mice M Paulsen, A Varese, N Pinpathomrat, FCM Kirsebom, M Paulsen, ... Frontiers in Immunology 11, 572747, 2020 | 6 | 2020 |
| Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases P Intapiboon, P Uae-Areewongsa, J Ongarj, R Sophonmanee, ... npj Vaccines 7 (1), 149, 2022 | 3 | 2022 |
| A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge E Stylianou, N Pinpathomrat, O Sampson, A Richard, M Korompis, ... Frontiers in Immunology 14, 1263457, 2023 | 1 | 2023 |
| Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study P Sripongpun, N Pinpathomrat, R Sophonmanee, J Ongarj, ... Vaccines 11 (9), 1455, 2023 | 1 | 2023 |
| Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP N Tongsengkee, S Surasombatpattana, W Tanomkiat, P Siripaitoon, ... Journal of Clinical Medicine 12 (4), 1388, 2023 | 1 | 2023 |
| Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA) R Tanner, A Zelmer, H Painter, E Stylianou, N Pinpathomrat, ... bioRxiv, 2021.02. 14.431105, 2021 | 1 | 2021 |
| Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study R Sophonmanee, P Preampruchcha, J Ongarj, B Seeyankem, ... Vaccines 12 (2), 109, 2024 | | 2024 |
| Effectiveness of plant-based hand sanitizer incorporating Quercus infectoria gall extract T Waen-Ngoen, S Wunnoo, OF Nwabor, S Bilhman, K Dumjun, J Ongarj, ... Journal of Applied Microbiology 134 (12), lxad295, 2023 | | 2023 |
| Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic … P Intapiboon, N Pinpathomrat, S Juthong, P Uea-Areewongsa, J Ongarj, ... Vaccines 11 (3), 537, 2023 | | 2023 |
Helen McShaneThe Jenner Institute, University of OxfordVerified email at ndm.ox.ac.uk
